Startup Funding & IP Watch
Etched Raised $700M: 4 Grant Records, 14 Application Records — What First Customer Delivery Means for Its IP Story
Startup briefs
Short reads on newly funded companies and what their patent filings actually cover, written from the published record. New briefs are added here as the funding rounds land.
- Abcuro. Abcuro raised a $66M Series D. Read how its seven patent families, one granted, sit in a crowded biologics claim space and where the claims land.
- AssistMe. AssistMe raised $7.5M with seven patent families, three granted, in a crowded claim space. Read what the filings and its hiring say about its position.
- Castelion. Castelion raised an $800M Series C with no public patent filings under its name. Read what the publication window means for a company founded in 2022.
- Georgiamune. Georgiamune raised a $92.7M Series B on 12 patent families across six patent offices, one granted. Read what the immunotherapy portfolio covers.
- Gravis Robotics. Gravis Robotics raised a $200M Series A on three patent families filed in 2024, none granted yet. Read what the publication lag means for its IP.
- Groq. Groq raised a $350M Series A on 60 patent families, 37 granted, with NVIDIA as both investor and heaviest citer. Read what the portfolio covers.
- Hubble Network. Hubble Network raised $30M with eight US patent families, six granted, in CPC groups densely worked by Qualcomm. Read how its patents sit by the standard.
- Leal Therapeutics. Leal Therapeutics raised a $30M Series A on seven patent families, all filed in 2024 and none granted yet. Read where its science is concentrated.
- SweGan. SweGaN raised a $14M Series B with seven patent families, four granted, and a last public filing from 2021. Read what the GaN-on-SiC portfolio shows.
To commission this kind of analysis on a company or a sector, get in touch.
